IGF1 and breast cancer: For example, when RM11A murine breast cancer cells that express high levels of exogenous IGF-IR were treated with IGF-I or IGF-II, the proliferative/survival potential of these cells was not enhanced, suggesting a ligand-independent mechanism [45].